At the Institute for Biomedicine, we perform Precision Health research and translation by integrating and converging multidisciplinary knowledge from our Health Data Science and Translational Biology programs. These two areas work hand in hand: Health Data Science provides large-scale insights from epidemiological and clinical data, while Translational Biology brings those findings into the lab to investigate disease mechanisms in detail, using advanced human cell models, such as organoids, microphysiological systems and engineered human tissues in order to study biological processes at the cellular level. New insights are then fed back into data-driven research.

By combining these approaches, our researchers investigate the factors that influence cardiovascular, kidney, metabolic and neurological health. This continuous exchange between data and biology helps us understand how diseases emerge and progress. Ultimately this supports the development of targeted strategies for prevention and treatment.

Our work is rooted in South Tyrol, Italy, where we have built a foundation for sustainable biomedical research that reaches far beyond the region. With the CHRIS study, a longitudinal population study involving 13,393 participants, we've created a valuable resource of health data with extensive molecular characterization. It enables us to observe how health conditions and disease progress over time, thus providing crucial insights for better understanding and protecting health at both individual and population levels. As part of Eurac Research, we are committed to responsible, ethical and transparent science.

We collaborate strategically across academia, healthcare, and industry to increase our scientific impact and contribute to real-world healthcare solutions. Our goal is to make the Institute an emerging center of excellence for precision health research in Italy and beyond.

To learn more about us, take a look at our history, culture and organizational structure.